Tracy L Bale

Title: Tracy L Bale: Innovator in Angiogenesis Research

Introduction

Tracy L Bale is a prominent inventor based in San Diego, CA, known for her significant contributions to the field of angiogenesis research. With a total of 2 patents, her work focuses on the physiological responses to stress and the implications for anxiety and depression.

Latest Patents

Bale's latest patents include a method of inhibiting angiogenesis through the administration of a corticotropin releasing factor receptor 2 (CRFR2) agonist. This invention provides transgenic mice deficient in CRFR2, which are valuable for studying anxiety, depression, and the physiology of the hypothalamic-pituitary-adrenal (HPA) axis. The research indicates that CRFR2 null mutant mice are hypersensitive to stress and exhibit increased anxiety-like behavior. Additionally, her patent on corticotropin releasing factor receptor 2 deficient mice highlights the critical role of CRF in stress response and its distinct affinities for CRFR1 and CRFR2.

Career Highlights

Tracy L Bale is affiliated with the Research Development Foundation, where she continues to advance her research in the field. Her innovative work has opened new avenues for understanding the mechanisms of stress and anxiety, contributing to potential therapeutic strategies.

Collaborations

Bale collaborates with notable colleagues, including Wylie Walker Vale, Jr. and Kuo-Fen Lee, enhancing the impact of her research through shared expertise and insights.

Conclusion

Tracy L Bale's contributions to the field of angiogenesis and stress response research underscore her role as a leading inventor. Her innovative patents and collaborative efforts continue to influence the scientific community and pave the way for future advancements.